resiquimod has been researched along with birb 796 in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) |
---|---|---|---|---|---|
465 | 14 | 318 | 137 | 5 | 80 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagby, GC; Garbati, MR; Hays, LE; Keeble, W; Rathbun, RK; Yates, JE | 1 |
1 other study(ies) available for resiquimod and birb 796
Article | Year |
---|---|
FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Fanconi Anemia Complementation Group A Protein; Fanconi Anemia Complementation Group C Protein; Hematopoietic Stem Cells; Humans; Imidazoles; Inflammasomes; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Macrophages; Mice, Knockout; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2013 |